Malignant gliomas are lethal cancers that display cellular hierarchies with cancer stem cells at the apex. Glioma stem cells (GSCs) are not uniformly distributed, but rather located in specialized niches, suggesting that the cancer stem cell phenotype is regulated by the tumor microenvironment. Indeed, recent studies show that hypoxia and its molecular responses regulate cancer stem cell maintenance. We now demonstrate that acidic conditions, independent of restricted oxygen, promote the expression of GSC markers, self-renewal and tumor growth. GSCs exert paracrine effects on tumor growth through elaboration of angiogenic factors, and low pH conditions augment this expression associated with induction of hypoxia inducible factor 2a (HIF2a), a GSC-specific regulator. Induction of HIF2a and other GSC markers by acidic stress can be reverted by elevating pH in vitro, suggesting that raising intratumoral pH may be beneficial for targeting the GSC phenotype. Together, our results suggest that exposure to low pH promotes malignancy through the induction of a cancer stem cell phenotype, and that culturing cancer cells at lower pH reflective of endogenous tumor conditions may better retain the cellular heterogeneity found in tumors.
Malignant gliomas are intrinsic brain tumors without current cures. 1 The prognosis for a grade IV glioma (glioblastoma; GBM) is less than 14-months survival after diagnosis, even with maximal surgical resection, radiation and chemotherapy. 2 The poor outcome for malignant glioma patients is largely due to tumor recurrence post treatment, often within 3 cm of the original site. 1 Recurrence may be due to the survival of a sub-population of glioma cells that drive tumor growth. These tumor-initiating cells have some characteristics of normal neural stem cells, including the expression of stem cell markers and the ability to self-renew, and are therefore called glioma stem cells (GSCs) . GSCs have been shown to be highly tumorigenic, pro-angiogenic and resistant to therapy compared with the majority of tumor cells, suggesting the importance of targeting GSCs for novel glioma therapies. 3, 4 Immunohistochemistry of human specimens has revealed that GSCs are highly prevalent in specific niches within the glioma rather than being equally distributed throughout the tumor. [5] [6] [7] These data suggest that microenvironmental conditions present in solid tumors can be critical for the regulation of molecular and biological properties of GSCs. Indeed, data from our laboratory and others demonstrated that exposure to low-oxygen tension or hypoxia-a common microenvironmental condition in solid tumors-increases expression of cancer stem cell markers including CD133 and HIF2a. [6] [7] [8] [9] Demonstration that hypoxia can influence the GSC phenotype led to GSC paradigms incorporating extrinsic factors and tumor-cell plasticity. [8] [9] [10] These more dynamic, rather than strictly hierarchical, models suggest that understanding the GSC microenvironment may offer new avenues for therapeutic intervention.
An important tumor microenvironment that has yet to be evaluated in the context of the GSC paradigm is pH. For a wide variety of cancers, extracellular solid tumor pH has been determined to be significantly more acidic than in normal tissues and may decrease as tumor size increases. [11] [12] [13] [14] [15] Tumor pH can be highly variable within one tumor with localized regions of acidity. 11, 13 Electrode measurements of pH in human brain tumors have been as low as 5.9 with a mean around 6.8, whereas normal brain tissue has a pH of B7.1.
12 Although an acidic microenvironment is often considered to be integrally linked with hypoxia, in vivo glioma xenograft studies demonstrated the presence of oxygenated, but acidic brain tumor regions, 16 suggesting the potential for independent effects of hypoxia and low pH. Together, these data demonstrate that acidic stress is an established microenvironmental component of gliomas.
An acidic pH shift within solid tumors can regulate multiple biological processes: these include proliferation, angiogenesis, immunosuppression, invasion and chemoresistance. [11] [12] [13] [14] [15] In gliomas, low pH may increase angiogenesis through the induction of vascular endothelial growth factor (VEGF). 16, 17 Reduced extracellular pH also increased the resistance of glioma cells to multiple drugs including topotecan and cisplatin, 18 although cell growth was decreased. 18, 19 As several of these pH-regulated biologies are also characteristically driven by GSCs, we sought to determine the effect of an acidic microenvironment on the GSC phenotype.
We provide evidence here for the first time that exposure to low pH promotes the expression cancer stem cell markers, self-renewal and tumorigenesis: hallmarks of GSCs.
Results
Tissue pH decreases in human glioma xenografts. The majority of experiments to determine the effects of an acidic microenvironment utilize pH 6.4-6.6 in vitro, although in vivo glioma pH has been measured to be as low as pH 5.9. 12, 13, 18, 19 To evaluate whether low pH could have a physiologically relevant influence on the CSC phenotype, we first determined the pH levels in the microenvironment of human glioma xenografts from which GSCs were derived. When extracellular pH was measured with an electrode probe, we observed a significant decrease in pH at the edge of the tumor compared with normal tissue (Supplementary Figure 1) . The intratumoral extracellular pH at the center of the glioma xenograft was even further decreased when compared with the tumor edge (Supplementary Figure 1) . These data strongly suggest that low pH is an important component of the in vivo tumor microenvironment to which GSCs are exposed.
Exposure to low pH maintains and promotes expression of glioma stem cell markers. To elucidate whether acidic stress could influence the phenotype of GSCs, isolated GSCs were exposed to standard pH (7.5) or an acidic pH (6.5). Cells grown in low pH conditions displayed a consistent increase in cancer stem cell markers including Olig2, Oct4 and Nanog (Figures 1a-c; Supplementary Figure 2 ), but not Sox2 (data not shown). Olig2 mRNA was significantly induced greater than fourfold in all preparations of GSCs tested ( Figure 1a ; Supplementary Figure 2A) , whereas Oct4 and Nanog were usually increased greater than twofold (Figures 1b and c; Supplementary Figure 2B ). To determine whether these increases in stem cell markers represented a greater ability to maintain the cancer stem cell phenotype, GSCs were placed in normal or acidic media containing serum to stimulate differentiation. In the presence of serum, GSCs cultured at pH 7.5 acquired expression of the astrocyte marker glial fibrillary acidic protein (GFAP), whereas exposure to acidic conditions prevented GFAP expression (Figure 1d; Supplementary Figure 3) . These data suggest that low pH may prevent terminal differentiation and facilitate cancer stem cell maintenance.
We next sought to determine whether exposure to acidic conditions would promote expression of GSC markers in cultures initially depleted of GSCs. Similar to the results in GSCs, we found that mRNA expression of Olig2, Oct4 and Nanog increased when cells were treated with media at pH 6.5 relative to pH 7.5 (Figures 2a-c; Supplementary Figure 4) . However, the induction of stem cell markers was often more potent in GSC-depleted cultures (Figures 2a-c Figure 3 ) are decreased in cells exposed to pH 6.5. In contrast, GFAP and Tuj1 are highly prevalent in GSC-depleted cells under typical cell culture conditions (Figures 2d and 3 Supplementary Figure 5 ). Furthermore, bulk glioblastoma cells isolated directly from a patient specimen and exposed to acidic stress had increased percentages of CD133 þ cells (Supplementary Figure 6 ). These data demonstrate that reductions in pH increase expression of GSC markers while decreasing differentiation marker expression.
Acidic stress promotes functional indicators of the glioma stem cell phenotype. We next sought to determine whether the changes in GSC markers upon low pH could be sufficient to influence the cellular behaviors of neurosphere formation and tumorigenic capacity associated with GSCs. We noted morphological changes on exposure to acidic conditions (but not typical culture pH) consistent with the acquisition of neurosphere-like structures when identical cell numbers were plated (Figures 3a and 4a ). These morphological changes appeared to be indicative of the acquisition of greater neurosphere formation capacity, as the percentage of wells with neurospheres significantly increased with low pH treatment (Figure 4b ). We then sought to determine whether the elevation of this artificial indicator of self-renewal in vitro was consistent with promotion of tumor formation in vivo. When mice were intracranially implanted with cells exposed to acidic stress, the survival of mice bearing human glioma xenografts was increased in comparison with cells cultured under typical pH (Figure 4c ). Similarly, we observed an increase in the size of subcutaneous tumors initiated with low pH treated cells with a trend towards statistical significance (Figure 4d ). Immunohistochemical analysis of intracranial (Figure 4e ; Supplementary Figure 7 ) and subcutaneous (data not shown) tumors suggested that gliomas originating from cells exposed to acidic stress had increased microvascular density and volume. Although these data support the notion that acidic pH promotes a pro-angiogenic GSC-driven microenvironment, tumor vessel density depends on the metabolic requirements of the growing tumor. Thus, differences in tumor size and location will directly influence the development of the glioma vasculature post-initiation.
Low pH induces expression of angiogenic factors in human glioma cells. The tumorigenic capacity of GSCs is due, in part, to an ability to promote angiogenesis associated with increased production of vascular endothelial growth factor (VEGF). 20 VEGF levels increase in acidic cell Figure 1 Cancer stem cell markers are maintained in acidic GSC-enriched cultures. (a-c) Expression of cancer stem cell markers was evaluated in CD133 þ cells isolated from three different human glioma xenografts and subsequently treated with acidic (pH 6.5) or normal (pH 7.5) cell culture media for 6 days. RNA was collected using Qiagen RNAeasy kits, reverse transcribed and analyzed for the specific genes indicated using real-time PCR. n ¼ 2 for each tumor type. (a) Treatment with low pH increased expression of Olig2 mRNA in T1863, T4302 and T4121 GSC-enriched cultures. (b) Exposure to reduced pH increased expression of Oct4 mRNA in T1863, T4302 and T4121 GSCs. (c) Acidic stress increased expression of Nanog mRNA in T1863, T4302 and T4121 GSCs. (d) All GSCs shown were cultured in the presence of serum to induce differentiation. Immunofluorescence for the astrocyte marker glial fibrillary protein (GFAP, green) and the nuclear stain DAPI (blue) demonstrates the presence of the differentiation cell marker GFAP in glioma stem cells cultured at pH 7.5. In contrast, GFAP is rarely expressed in cells exposed to acidic stress culture, 16, 17 suggesting that VEGF could be an important component of the low pH-driven CSC phenotype. To determine the effect of an acidic microenvironment on GSC secretion of a panel of angiogenic factors including VEGF, we collected conditioned media from cells pre-cultured in normal cell culture conditions or under low pH. Using the GSC conditioned media from pH 7. Figure 2 Cancer stem cell markers increase in GSC-depleted cultures after treatment with low pH. (a-c) Expression of cancer stem cell markers was evaluated in CD133À cells isolated from three different human glioma xenografts and subsequently cultured under low pH (6.5) or typical cell culture conditions (pH 7.5) for 6 days. RNA was collected using Qiagen RNAeasy kits, reverse transcribed, and analyzed for the specific genes indicated using real-time PCR. n ¼ 2 for each tumor type. (a) Treatment with low pH increased expression of Olig2 mRNA in T1863, T4302 and T4121 GSC-depleted cultures. (b) Exposure to low pH increased expression of Oct4 mRNA in T1863, T4302 and T4121 GSC-depleted cultures. (c) Acidic stress increased expression of Nanog mRNA in T1863, T4302 and T4121 GSC-depleted cultures. (d) Immunofluorescence for the stem cell marker Nanog (green), astrocyte marker glial fibrillary protein (GFAP, red) and the nuclear stain DAPI (blue) demonstrates the presence of Nanog in cells cultured at pH 6.5. In contrast, the differentiation marker GFAP is highly present in cells cultured at pH 7.5, but rarely when cells were exposed to pH 6.5 threefold increase in VEGF levels upon low pH treatment (Figure 5b) . A similar fold increase in secreted VEGF with acidic conditions was detected using ELISA (Figure 5c ).
These data demonstrate that GSCs exposed to low pH produce elevated levels of secreted factors, which have the capacity to modulate tumor growth. To determine whether the effect of acidic stress on angiogenic factors was equivalently prevalent in the majority of tumor cells, we performed identical experiments with cultures initially depleted of GSCs. Using the angiogenesis array, we found that low pH potently increased levels of IL-8, TIMP1, TIMP2 and VEGF (Figure 5d ). The intensity of VEGF staining on the angiogenesis array increased approximately threefold ( Figure 5e ) and was confirmed by a 3.5-fold increase in secreted VEGF as measured by ELISA. This elevation of VEGF and the other angiogenic factors in the low pH-exposed GSC-depleted cultures resulted in a secreted protein profile that was very similar to that of GSCs cultured at normal pH (Figures 5a and d) .
To further evaluate whether the increase in VEGF protein was due to an increase in VEGF transcription, we determined VEGF mRNA levels using quantitative real-time PCR. We found that low pH increased VEGF mRNA B2-to 20-fold depending on the glioma cells tested in both GSC-enriched and -depleted cultures (Figure 5g; Supplementary Figure 8A) . Together, these data demonstrate that promotion of VEGF and other angiogenic factors can be due to transcriptional changes in response to acidic stress. Furthermore, exposure to an acidic microenvironment is likely to contribute to tumor growth and maintenance through promotion of a GSC-like angiogenic phenotype.
Induction of HIF2a and HIF target genes by acidic stress. The most well-characterized pathway that regulates angiogenesis and VEGF involves the hypoxia response factors (HIFs). We therefore sought to evaluate HIF2a and HIF1a gene expression in our low pH-treated glioma cells. In GSC-enriched cultures, we found that HIF2a mRNA was increased greater than threefold in three different GSC preparations (Figure 6a ; Supplementary Figure 8B ). In contrast, we observed variable effects on HIF1a mRNA with either a minimal induction or more potent and statistically significant repression (Figure 6b ; Supplementary Figure 8C ). As our lab and others previously determined that HIF2a is a GSC marker and that increased HIF2a mRNA is characteristic of GSCs, 6,7 the promotion of HIF2a by exposure to acidic stress suggests that low pH facilitates GSC maintenance. (f) ELISA demonstrates elevated VEGF protein expression in the conditioned media of T1863 GSC-depleted cultures pretreated at pH 6.5. n ¼ 2. (g) Real-time PCR demonstrates increased VEGF mRNA in GSC-enriched or -depleted cultures isolated from T1863, T4302 or T4121 xenografts. n ¼ 2 for each tumor type. RNA was collected after 6 days of treatments with media at pH 6.5 or pH 7.5 using Qiagen RNAeasy kits. RNA was reverse transcribed and analyzed for VEGF using real-time PCR Similar to these results, HIF2a mRNA was increased greater than sevenfold in every GSC-depleted culture exposed to low pH (Figure 6c ) whereas HIF1a mRNA was repressed (Figure 6d ). These data suggested that HIF2a may be the HIF primarily responsible for VEGF induction in acidic conditions. However, HIFs are most well known for being regulated at the level of protein stability and HIF1a protein has been shown to be stabilized under reduced pH. 21 We therefore determined whether the changes in HIF transcription were sufficient to induce changes in protein expression using western analysis. We confirmed that HIF2a protein was dramatically increased with low pH treatment of a glioma cell line or two different cultures of GSC-depleted cells (Figure 6e ). In contrast, HIF1a protein expression was either decreased or relatively unchanged after acidic stress (Figure 6e ). Consistent with our previous reports, 6 ,8 the hypoxia mimetic desferrioxamine (DFX) was sufficient to induce both HIF1a and HIF2a in GSC-depleted cultures (Figure 6e ). Thus, low pH preferentially elevates HIF2a mRNA and protein in glioma cells. Considering our previous data that HIF2a overexpression in GSC-depleted cultures is sufficient to promote tumorigenesis, 8 these data suggest that elevation of HIF2a may be one mechanism through which an acidic microenvironment promotes tumor growth.
To determine whether the elevation of HIF2a protein induced changes in gene expression, we characterized levels of two genes, which were previously shown to be HIF2a dependent and regulate cancer cell growth or survival: glucose transporter type 1 (Glut1) and the proteinase inhibitor SerpinB9. 6, 22, 23 Both Glut1 and SerpinB9 may be upregulated in cancer cells to facilitate cell growth or survival, 24, 25 indicating there may be functional consequences of the dysregulation of these genes in glioma. We found that low pH induced Glut1 30% or more (Figure 7a ). SerpinB9 was also induced by low pH threefold or more in three different GSC preparations (Figure 7b ). Similar to the potent induction of HIF2a in GSC-depleted cells, Glut1 and SerpinB9 were induced more than fourfold in all glioma cells tested (Figures 7c and d) . These data strongly suggest that an acidic microenvironment can produce a specific elevation of HIF2a, which promotes the expression of known HIF target genes, including VEGF, Glut1 and SerpinB9. Together, our data demonstrate that the production of VEGF and the increase in tumorigenesis resulting from low pH is due to the promotion of a cancer stem cell phenotype, which is likely dependent, in part, on the elevation of HIF2a.
We next sought to determine whether this promotion of a cancer stem cell phenotype by acidic stress could be reverted by exposure to a non-acidic pH. Similar to our previous results, we found that acidic stress induced the expression of HIF2a and the HIF2a target genes VEGF, Glut1 and SerpinB9 in D456MG GSC-depleted cultures (Figure 8 ). However, culture at pH 7.5 after exposure to pH 6.5 was sufficient to prevent maintenance of the induction of HIF2a and most of its T1863  T4121  T4302   T1863  T4121  T4302   T1863  T4121  T4302   pH   pH  pH  pH 6.5 DFX 6.5 7.5 DFX 6.5 Figure 6 Exposure to low pH induces HIF2a mRNA. (a and b) Expression of HIFs was evaluated in CD133 þ enriched (a and b) or CD133 þ depleted (c and d) cells isolated from three different human glioma xenografts and subsequently treated with acidic (pH 6.5) or normal (pH 7.5) cell culture media for 6 days. RNA was collected using Qiagen RNAeasy kits, reverse transcribed and analyzed for HIF2a (a) or HIF1a (b) using real-time PCR. n ¼ 2 for each tumor type. (c) HIF2a mRNA increases in T1863, T4302 and T4121 GSC-depleted cultures exposed to pH 6.5 compared with those cultured at pH 7.5. (d) Exposure to low pH represses HIF1a mRNA in T1863, T4302 and T4121 GSC-depleted cultures. (e) Western analysis demonstrates that HIF2a protein is elevated after treatment with acidic media. Totalcell lysates were collected from the human glioma cell line U87 MG or GSC-depleted cultures isolated from T4302 and T4121 xenografts treated with media at pH 6.5 or pH 7.5 for 14 days. In GSC-depleted cultures, addition of 100 mM of the hypoxia mimetic desferrioxamine (DFX) in pH 7.5 media was included as a positive control for HIF expression. Equivalent amounts of total protein were analyzed with the indicated antibodies. Tubulin expression was used as a loading control targets (Figure 8) . Similarly, we found that expression of the GSC markers Olig2 and Nanog was also reduced to near baseline levels by restoration of a non-acidic pH (Supplementary Figure 4 ). These data suggest that tumor cell plasticity towards a GSC phenotype may be reduced by targeting intratumoral pH. Figure 8 Promotion of HIF2a and HIF2a target genes by acidic stress can be reverted by increasing pH. CD133À cells isolated from D456 MG xenografts were exposed to acidic (pH 6.5) or typical (pH 7.5) cell culture media for a total of 10 days. After the initial 6 days, cells exposed to acidic pH were subsequently exposed to pH 7.5 (6.5-7.5) for 4 days. RNA was collected using Qiagen RNAeasy kits, reverse transcribed and analyzed for the specific genes indicated using real-time PCR. Figure 7 Low pH treatment increases the expression of the HIF2a target genes Glut1 and SerpinB9. mRNA expression was evaluated in CD133 þ enriched (a and b) or CD133 þ depleted (c and d) cells isolated from three different human glioma xenografts and subsequently treated with acidic (pH 6.5) or normal (pH 7.5) cell culture media for 6 days. RNA was collected using Qiagen RNAeasy kits, reverse transcribed and analyzed for the Glut1a (a and c) or SerpinB9 (b and d) using real-time PCR. n ¼ 2 for each tumor type
Discussion
The elevated metabolism of rapidly growing tumors results in the consumption of energy from a variety of carbon sources. During this process, hydrogen ions as well as acidic metabolites including lactic acid and carbonic acid are produced. These acidic products are actively transported to the extracellular space via cell membrane-associated complexes including Na þ /H þ exchangers, monocarboxylate transporters (MCT), Na þ HCO3-transporters and Cl-/HCO3-exchangers. Although often considered to be constitutively expressed, oncogenes may induce exchanger activity and/ or expression, indicating the potential for transformation to promote hydrogen ion export. 26, 27 Once hydrogen ions and acidic metabolites are extracellular, they may be removed via the vasculature. However, the combination of elevated acidic metabolite production and poor tumor circulation often results in accumulation of hydrogen ions and a resulting drop in intratumoral pH. 12, 15 Published reports and our data demonstrating the reduced pH of human gliomas and their xenografts demonstrate that acidic pH is an important microenvironmental component of brain tumors. 12, 13 However, cell culture media have a slightly alkaline pH at baseline and are designed to maintain a relatively neutral pH during cellular growth. Standard culture conditions therefore cannot accurately represent the acidic microenvironment of human tumors and are likely to underestimate the importance of low pH conditions on tumor cell signaling and behaviors. Considering our findings that acidic stress promotes the GSC phenotype and other studies linking hypoxia to GSCs, culture under reduced oxygen tension and pH may be a more appropriate model to facilitate in vitro maintenance of the cellular heterogeneity found in vivo.
Tumor growth and angiogenesis are tissue-specific processes regulated by the microenvironment, which includes acidic pH in solid tumors. Although our data demonstrate that the growth of gliomas is enhanced by exposure of implanted cells to acidic stress, changes were most apparent in the orthotopic intracranial, rather than subcutaneous, model. These differences may be due to distinctions in the tumor microenvironment and vasculature between these sites. For example, VEGF isoforms have been shown to have divergent activities in the promotion of tumor angiogenesis depending on the location of glioma cell implantation with greater effects on intracranial rather than subcutaneous tumor growth. 28 HIF's effects on the growth of transformed astrocytes also differ depending on whether cells are implanted subcutaneously or intracranially. 29 Furthermore, implantation of glioma cells at different anatomical sites differentially regulates ligands for the integrins, 30 known as GSC regulators. 31 These data strongly suggest that distinctions in the tumor microenvironment may explain the differences in statistical significance observed with subcutaneous and intracranial tumor cell implantations. The molecular mechanisms through which an acidic microenvironment could promote the GSC phenotype remain to be fully determined, but we have identified acquisition of HIF2a as an important contributor. HIF1a and HIF2a are most well known for being regulated at the level of protein stability through ubiquitination by the Von Hippel Lindau (VHL) tumor suppressor gene and subsequent targeting for proteasomal degradation. Although previous studies suggested that HIFa may be stabilized under low pH through nucleolar sequestration of VHL, 22 we did not observe significant changes in HIF1a protein in glioma cells due to exposure to acidic pH. In contrast, HIF2a mRNA and protein were strongly upregulated, suggesting a critical role for this HIFa in an acidic microenvironment. These data further support recent studies delineating non-redundant functions for HIF2a and HIF1a in brain tumors and GSCs. 6, 7, 22 HIF2a-specific target genes, including Oct4, Glut1 and SerpinB9, 23, 32 which were increased by low pH, are elevated in GSCs. 6 In addition to directly binding target gene promoters, HIFa may promote the transcription of important stem cell factors through epigenetic modifications. Recent studies demonstrate that HIFa can induce the Jumonji family of histone demethylases to promote chromatin modification and tumor growth. [33] [34] [35] [36] It would therefore appear likely that changes in histone methylation could also result from HIF2a induction in acidic microenvironments. Thus, further exploration of the differential roles for HIF2a in stem cell and cancer biology, including epigenetic modifications, is warranted.
The ability of tumor microenvironmental conditions such as low pH to influence the GSC phenotype strongly suggests that it will be critical to target the GSC niche as well as GSCs directly. Targeting of GSC-specific molecular targets such as HIF2a is likely to be beneficial. However, removal of these GSCs may provide opportunistic space in the GSC niche for other tumor cells, which will then be exposed to hypoxia, acidic pH, or other as yet undefined GSC-promoting microenvironmental conditions (e.g. metabolic derangements). Subsequent to GSC directed therapies, microenvironmental cues in the GSC niche may then re-establish a subset of GSCs to maintain tumor cell homeostasis. If, however, GSCs and the GSC niche were targeted concurrently, GSCs may be eliminated along with tumor cell plasticity to a more GSC-like phenotype, as has been proposed in other models. 5, 10 One mechanism through which an acidic microenvironment may be targeted is through restoration of a neutral pH in growing tumors. A recent study in a breast cancer model demonstrated that treatment with sodium bicarbonate could be sufficient to increase tumor extracellular pH. 37 Increasing the pH of breast tumors was associated with reduced invasion, 37 a property associated with CSCs in breast cancer. 38 Similar results were determined in a computer simulation of the ability of system buffers to reduce extracellular pH. 39 Our data also demonstrate that restoring a nonacidic pH to cells exposed to acidic stress can reduce the elevation of HIF2a and other GSC markers induced by low pH. Although further experiments are needed, these data suggest the utility of targeting the acidic microenvironment as an anticancer stem cell therapy.
Materials and Methods
Measurement of intratumoral extracellular pH. An Orion 98-63 micro-pH electrode (Thermo Electron Corporation, Marietta, OH, USA), a 16-gauge beveled tip electrode (1.6 mm OD) coupled to an Orion 310 PerpHecT pH meter (Thermo Electron Corporation), was used to measure intratumoral pH. The beveled pH probe was inserted transcutaneously into the tumors. Measurements were taken in the edge and central region of the tumors as well as in the tumor-free subcutaneous region of the posterior cervical midline.
Isolation of cells and culture with pH treatment. Matched cultures enriched or depleted for GSCs were isolated from primary human brain tumor patient specimens or human glioblastoma xenografts as previously described, in accordance with a Duke University or Cleveland Clinic Institutional Review Board Protocol complying with national regulatory standards, with patients signing informed consent. 6, 40, 20 Isolated cells were separated by a magnetic sorting column using microbead-conjugated CD133 antibodies. We found that CD133 þ cells fulfilled the functional criteria of GSCs, including expression of GSC markers, self-renewal, multi-lineage differentiation and tumor propagation. To assess effects of low pH, media pH was altered with hydrochloric acid in accordance with previously published protocols. 18 Non-stem tumor cells were cultured in a DMEM/Neurobasal media adjusted to pH 7.5 or pH 6.5 containing 5% FBS, 5 ng/ml bFGF, and 5 ng/ml EGF and media were changed every other day for the indicated times. For stem cell maintenance studies, GSCs were cultured in Neurobasal adjusted to pH 7.5 or pH 6.5 containing 10 ng/ml bFGF and 10 ng/ml EGF, and media was changed every other day.
Semiquantitative PCR. PCR was performed on cDNA generated by Superscript III reverse transcriptase (Invitrogen, Carlsbad, OH, USA) from total RNA harvested from cells using RNAeasy Kit (Qiagen, Valencia, CA, USA) with indicated primers as previously described. 6, 8 Immunofluorescence. Immunofluorescence of isolated cells was performed similar to our previous description 6 using antibodies against GFAP (Sigma, St Louis, MO, USA), Nanog (Santa Cruz, Santa Cruz, CA, USA) and b III tubulin (Millipore, Billerica, MA, USA).
Angiogenesis antibody array. Conditioned media were harvested from the indicated cells pretreated for 6 days with the indicated pH and then cultured in identical media without growth factors for 24 h. TranSignal Human Angiogenesis Antibody Arrays (Panomics, Santa Clara, CA, USA) were twice incubated with 2 ml of conditioned media for 1.5 h and then processed according to the manufacturer's instructions as previously described. 20 Intensity of protein expression was quantified with ImageJ software, where indicated with the total mean intensity equal to the area multiplied by the mean intensity.
VEGF ELISA. Human VEGF Quantikine ELISA kits (R&D Systems, Minneapolis, MN, USA) were used according to the manufacturer's instructions and our previous reports 6, 20 with conditioned media harvested from cells pretreated for 6 days with the indicated pH and then cultured in identical media without growth factors for 24 h.
In vivo tumor formation. Intracranial orthotopic and subcutaneous transplantation of cells under specific pH conditions into nude mice was performed as described in accordance with a Cleveland Clinic Institutional Animal Care and Use Committee approved protocol concurrent with national regulatory standards as previously described. 6, 40, 20 Briefly, cells were counted after 6 days of exposure to indicated pH and 5000 cells were implanted into the right frontal lobes of athymic BALB/c nu/nu mice. Mice were maintained until the development of neurological symptoms. Tumors were subsequently frozen or paraffin embedded and stained with hematoxylin and eosin or for CD31 (BD Pharmingen, San Diego, CA, USA) with DAB Peroxidase kits (Vector Laboratories, Burlingame, CA, USA).
Statistical analysis. Descriptive statistics were generated for all quantitative data with presentation of means ± standard error. Significance was tested by unpaired t-test using GraphPad InStat 3.0 software (GraphPad Software Inc., La Jolla, CA, USA)or, when variances were significantly different, by one-way analysis of variance of log-transformed data using MedCalc software (MedCalc Software, Mariakerke, Belgium). For in vivo studies, Kaplan-Meier curves and logrank analysis were performed using MedCalc software.
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